(Reuters) – Haleon is recalling certain batches of its Robitussin adult cough syrup due to microbial contamination, the U.S. Food and Drug Administration (FDA) said. The consumer health company is recalling the cough syrup sold under the brand name „Robitussin Honey CF Max Day Adult“ in 4-ounce and 8-ounce bottles, as well as its 8-ounce nighttime version.
„The voluntary recall is limited to specific batches of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult, which are manufactured and sold exclusively in the United States,“ a Haleon spokesperson said in an email response.
The use of the contaminated medication could potentially cause severe or life-threatening adverse events such as fungal infections in patients with weakened immune systems, the FDA said in a press release on Wednesday.
However, Haleon has not received any reports of adverse events related to these syrups so far.
The company, which spun off from GSK in 2022, is notifying its dealers and customers directly and providing them with instructions for returning all the recalled medications, the regulatory agency said.
(Reporting by Christy Santhosh and Mariam Sunny in Bengaluru; Editing by Krishna Chandra Eluri)